Voriconazole

규격

137234-62-9CAS 번호

629-701-5EC 번호

(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-olIUPAC 명칭

C16H14F3N5O화학식

349.31 g/mol분자량

Voriconazole; 137234-62-9; Vfend; (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol; UK-109496; Voriconazol; (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol; Voriconazolum; UK-109,496; UK 109496; JFU09I87TR; NSC-759888; DTXSID5046485; (R-(R*,S*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol; CHEBI:10023; (alphaR,betaS)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol; DTXCID3026485; UK109496; RefChem:56222; UK109,496; J02AC03; 629-701-5; 941-833-8; (+/-)-Voriconazole; Voriconazole Vfend; MFCD00905717; Voriconzole; 4-Pyrimidineethanol, alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-, (alphaR,betaS)-; 188416-29-7; C16H14F3N5O; VCZ; Voriconazole, (+/-)-; CHEMBL638; USG4B1CD29; CPD000466350; VRC; 173967-54-9; (2R,3S)-2-(2,4-Difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-((1H)-1,2,4-triazol-1-yl)-butan-2-ol; 4-Pyrimidineethanol, alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-, (R-(R*,S*))-; Vorikonazole; Voriconazole [USAN:INN:BAN]; DRG-0301; SMR000466350; Vfend (TN); VFEND I.V.; UNII-JFU09I87TR; Voriconazole?; s1442; Voriconazole CRS; (alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol; Voriconazole (Standard); Voriconazole in combination with MGCD290; VORICONAZOLE [MI]; VORICONAZOLE [INN]; VORICONAZOLE [JAN]; VoriconazoleUK-109496; UNII-USG4B1CD29; VORICONAZOLE [USAN]; VORICONAZOLE [VANDF]; SCHEMBL36233; VORICONAZOLE [MART.]; MLS000759464; MLS001424082; MLS006010028; VORICONAZOLE [USP-RS]; VORICONAZOLE [WHO-DD]; VORICONAZOLE [EMA EPAR]; SCHEMBL29378592; SCHEMBL29449336; Voriconazole (JP18/USP/INN); Voriconazole - Bio-X trade mark; Voriconazole, >=98% (HPLC); DTXSID201019420; GLXC-07888; HMS2051N09; HMS3260M22; HMS3713F12; Pharmakon1600-01502346; VORICONAZOLE [ORANGE BOOK]; VORICONAZOLE [EP MONOGRAPH]; MSK10394; Tox21_500150; VORICONAZOLE [USP MONOGRAPH]; Voriconazole 2.0 mg/ml in Methanol; AC-823; BDBM50333117; EBC-06050; HY-76200R; NSC759888; AKOS005145705; CCG-100941; CS-1227; DB00582; FV29101; HY-W337569; KS-1157; NC00191; NSC 759888; NCGC00164622-04; NCGC00164622-06; NCGC00164622-17; NCGC00260835-01; 4-Pyrimidineethanol, alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-, (alphaR,betaS)-rel-; BV164532; HY-76200; SY072427; ( inverted exclamation mark_)-Voriconazole; ( inverted exclamation markA)-Voriconazole; CS-0448910; NS00007182; SW197571-2; V0116; V5886; C07622; D00578; EN300-119515; AB00639948-04; AB00639948-06; AB00639948_07; AB00639948_08; Voriconazole, VETRANAL(TM), analytical standard; F358084; Q412236; BRD-K06557128-001-06-2; BRD-K06557128-001-07-0; BRD-K06557128-001-08-8; Z1521553720; Voriconazole, European Pharmacopoeia (EP) Reference Standard; Voriconazole, United States Pharmacopeia (USP) Reference Standard; (2R,3S)-2,3-bis(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol; 2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl) butan-2-ol; Voriconazole, Pharmaceutical Secondary Standard: Certified Reference Material; (+/-)-Voriconazole; (aR,ssS)-rel-a-(2,4-Difluorophenyl)-5-fluoro-ss-methyl-a-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol; (R*,S*)-a-(2,4-Difluorophenyl)-5-fluoro-ss-methyl-a-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol; (+/-)-Voriconazole; (2RS,3SR)-2-(2,4-Difluorophen; (.ALPHA.R,.BETA.S)-A-(2,4-DIFLUOROPHENYL)-5-FLUORO-.BETA.-METHYL-.ALPHA.-(1H-1,2,4-TRIAZOL-1-YLMETHYL)-4-PYRIMIDINEETHANOL; (2R,3S)-2-(2,4-Difluoro-phenyl)-3-(5-fluoro-pyrimidin-4-yl)-1-[1,2,4]triazol-1-yl-butan-2-ol; (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl) butan-2-ol; (2R,3S)-2-(2,4-Difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol; (2r,3s)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1h-1,2,4-triazol-1-yl)butan-2-ol; 2R,3S-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol-4-Pyrimidineethanol, ?-(2,4-difluorophenyl)-5-fluoro-?-methyl-?-(1H-1,2,4-triazol-1-ylmethyl)-,?(?R,?S)-; 4-Pyrimidineethanol, |A-(2,4-difluorophenyl)-5-fluoro-|A-methyl-|A-(1H-1,2,4-triazol-1-ylmethyl)-, (|AR,|AS)-; 4-PYRIMIDINEETHANOL, A-(2,4-DIFLUOROPHENYL)-5-FLUORO-.BETA.-METHYL-.ALPHA.-(1H-1,2,4-TRIAZOL-1-YLMETHYL)-, (.ALPHA.R,.BETA.S)-; 4-Pyrimidineethanol, alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-, (alphaR,betaS)-rel; rel-(alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol동의어